Literature DB >> 18310479

Circulating endothelial microparticle levels predict hemodynamic severity of pulmonary hypertension.

Nicolas Amabile1, Christian Heiss, Wendy May Real, Petros Minasi, Dana McGlothlin, Eduardo J Rame, William Grossman, Teresa De Marco, Yerem Yeghiazarians.   

Abstract

RATIONALE: Circulating microparticles (MPs) are submicron membrane fragments shed from damaged or activated vascular cells. Endothelial MPs are a biological marker of dysfunctional endothelium. Vascular remodeling and endothelial dysfunction are involved in pulmonary hypertension (PH).
OBJECTIVES: We tested the hypothesis that circulating MPs are increased in patients with PH and that identifiable subgroups of MPs predict the hemodynamic severity of this condition progression.
METHODS: Patients (n = 24; age, 54 +/- 4 yr) undergoing right heart catheterization for precapillary PH without any endothelium-active vasodilator therapy participated in the study. Age- and sex-matched healthy control subjects (n = 20) were included. Endothelial (PECAM(+) [CD31(+)]/ CD41(-), VE-cadherin(+) [CD144(+)], and E-selectin(+) [CD62e(+)]), platelet (CD41(+)), leukocyte-derived (CD45(+)), and annexin V(+) MPs were measured by flow cytometry in platelet-free plasma from venous blood.
MEASUREMENTS AND MAIN RESULTS: Levels of circulating endothelial PECAM(+), VE-cadherin(+), E-selectin(+), and leukocyte-derived MPs, but not platelet and annexin V(+) MPs, were increased in subjects with PH compared with control subjects (P < 0.01 each). PECAM(+) and VE-cadherin(+) MP levels significantly correlated with mean pulmonary artery pressure (r = 0.92 and r = 0.87, respectively), pulmonary vascular resistance (r = 0.78 and r = 0.73), and mean right atrial pressure (r = 0.43, and r = 0.46) and correlated inversely with cardiac index (r = -0.59 and r = -0.52). These relationships were not observed for other MP subgroups, and persisted in multivariate analysis after adjustment for confounding factors.
CONCLUSIONS: In subjects with precapillary PH, levels of circulating endothelial and leukocyte MPs were increased compared with control subjects. In addition, levels of PECAM(+) and VE-cadherin(+), but not E-selectin(+), endothelial MPs predicted hemodynamic severity of the disease.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18310479     DOI: 10.1164/rccm.200710-1458OC

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  68 in total

Review 1.  Today's and tomorrow's imaging and circulating biomarkers for pulmonary arterial hypertension.

Authors:  Marjorie Barrier; Jolyane Meloche; Maria Helena Jacob; Audrey Courboulin; Steeve Provencher; Sébastien Bonnet
Journal:  Cell Mol Life Sci       Date:  2012-03-25       Impact factor: 9.261

2.  Specific cell-derived microvesicles: Linking endothelial function to carotid artery intima-media thickness in low cardiovascular risk menopausal women.

Authors:  Virginia M Miller; Brian D Lahr; Kent R Bailey; Howard N Hodis; Sharon L Mulvagh; Muthuvel Jayachandran
Journal:  Atherosclerosis       Date:  2015-12-28       Impact factor: 5.162

3.  Circulating endothelial microparticles as a measure of early lung destruction in cigarette smokers.

Authors:  Cynthia Gordon; Kirana Gudi; Anja Krause; Rachel Sackrowitz; Ben-Gary Harvey; Yael Strulovici-Barel; Jason G Mezey; Ronald G Crystal
Journal:  Am J Respir Crit Care Med       Date:  2011-03-11       Impact factor: 21.405

4.  Microparticles in systemic sclerosis: Potential pro-inflammatory mediators and pulmonary hypertension biomarkers.

Authors:  Matthew R Lammi; Lesley Ann Saketkoo; Samuel C Okpechi; Mohamed A Ghonim; Dorota Wyczechowska; Natalie Bauer; Kusma Pyakurel; Saito Saito; Bennett P deBoisblanc; A Hamid Boulares
Journal:  Respirology       Date:  2019-02-12       Impact factor: 6.424

Review 5.  Microparticles and cardiovascular diseases.

Authors:  Christos Voukalis; Eduard Shantsila; Gregory Y H Lip
Journal:  Ann Med       Date:  2019-06-17       Impact factor: 4.709

6.  Increased circulating endothelial microparticles and carotid atherosclerosis in obstructive sleep apnea.

Authors:  Chang-Ho Yun; Keun-Hwa Jung; Kon Chu; So-Hyun Kim; Ki-Hwan Ji; Hee-Kwon Park; Hwan-Cheol Kim; Soon-Tae Lee; Sang-Kun Lee; Jae-Kyu Roh
Journal:  J Clin Neurol       Date:  2010-06-30       Impact factor: 3.077

7.  Persistence of circulating endothelial microparticles in COPD despite smoking cessation.

Authors:  Yael Strulovici-Barel; Michelle R Staudt; Anja Krause; Cynthia Gordon; Ann E Tilley; Ben-Gary Harvey; Robert J Kaner; Charleen Hollmann; Jason G Mezey; Hans Bitter; Sreekumar G Pillai; Holly Hilton; Gerhard Wolff; Christopher S Stevenson; Sudha Visvanathan; Jay S Fine; Ronald G Crystal
Journal:  Thorax       Date:  2016-07-26       Impact factor: 9.139

Review 8.  The role of microparticles in the pathogenesis of rheumatic diseases.

Authors:  Christian Beyer; David S Pisetsky
Journal:  Nat Rev Rheumatol       Date:  2009-12-01       Impact factor: 20.543

Review 9.  Genomics of pulmonary arterial hypertension: implications for therapy.

Authors:  Mark W Geraci; Todd M Bull; Rubin M Tuder
Journal:  Heart Fail Clin       Date:  2010-01       Impact factor: 3.179

Review 10.  Endothelial and Smooth Muscle Cell Interactions in the Pathobiology of Pulmonary Hypertension.

Authors:  Yuansheng Gao; Tianji Chen; J Usha Raj
Journal:  Am J Respir Cell Mol Biol       Date:  2016-04       Impact factor: 6.914

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.